Amgen will buy a manufacturing facility in Ireland from US drug giant Pfizer, securing the site’s workforce.
The 37,000 sqm plant in Dun Laoghaire near Dublin, houses a range of aseptic manufacturing capabilities, freeze-drying technologies and liquid vial filling operations
The deal, financial terms of which ere not disclosed, “anticipates that the majority of the employees at the site, some 240 people, will transfer their employment to Amgen.”
The US biotechnology firm will continue to produce some Pfizer biologic drug products at the facility for an interim period. Also under the deal, the remaining 40 people employed at the site will continue to work for Pfizer.
Paul Duffy, VP of primary care at Pfizer Global Supply said, "This is a good day for colleagues and for Ireland Inc. as it proves we remain an attractive location for high calibre investment.
Duffy added that: “We continue to actively engage in exploring opportunities to divest our Loughbeg and Shanbally plants in Cork and remain focused on delivering successful outcomes."